FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2163115842> ?p ?o ?g. }

• W2163115842 endingPage "622" @default.
• W2163115842 startingPage "611" @default.
• W2163115842 abstract "The prevalence of atherosclerotic renal artery stenosis is high, ∼7% in individuals older than 65 years and ∼50% in patients with diffuse arterial disease, and it is increasingly frequent in an aging population. About 10% to 15% of atherosclerotic renal artery stenosis cases lead to the development of resistant hypertension and/or ischemic nephropathy. The management of ischemic nephropathy may include medical therapy and/or revascularization. In the past, revascularization required surgical bypass or endarterectomy, accompanied by the morbidity and mortality associated with a major surgical procedure. During the last few decades, less invasive endovascular procedures such as percutaneous transluminal renal artery angioplasty with stent placement have become available. At the same time, new antihypertensive and cardiovascular drugs have been developed, which may preclude revascularization, at least in some cases. The indications of each of these therapeutic options have changed over time. This review offers a temporal perspective on the course of technical and scientific advances and the accompanying change in clinical practice for the treatment of ischemic nephropathy. The latest randomized clinical trials, including the CORAL (Cardiovascular Outcomes in Renal Atherosclerotic Lesions) trial, the largest on the subject, as well as a meta-analysis of these studies, have indicated that the best approach is medical therapy alone. There is evidence that revascularization brings no additional benefit, at least in low-risk and stable atherosclerotic renal artery stenosis. High-risk patients, especially those with recurrent flash pulmonary edema, could benefit from percutaneous transluminal renal artery angioplasty and stent placement, but there is no definitive evidence and the treatment choice should take into account the risks and potential benefits of the procedure. The prevalence of atherosclerotic renal artery stenosis is high, ∼7% in individuals older than 65 years and ∼50% in patients with diffuse arterial disease, and it is increasingly frequent in an aging population. About 10% to 15% of atherosclerotic renal artery stenosis cases lead to the development of resistant hypertension and/or ischemic nephropathy. The management of ischemic nephropathy may include medical therapy and/or revascularization. In the past, revascularization required surgical bypass or endarterectomy, accompanied by the morbidity and mortality associated with a major surgical procedure. During the last few decades, less invasive endovascular procedures such as percutaneous transluminal renal artery angioplasty with stent placement have become available. At the same time, new antihypertensive and cardiovascular drugs have been developed, which may preclude revascularization, at least in some cases. The indications of each of these therapeutic options have changed over time. This review offers a temporal perspective on the course of technical and scientific advances and the accompanying change in clinical practice for the treatment of ischemic nephropathy. The latest randomized clinical trials, including the CORAL (Cardiovascular Outcomes in Renal Atherosclerotic Lesions) trial, the largest on the subject, as well as a meta-analysis of these studies, have indicated that the best approach is medical therapy alone. There is evidence that revascularization brings no additional benefit, at least in low-risk and stable atherosclerotic renal artery stenosis. High-risk patients, especially those with recurrent flash pulmonary edema, could benefit from percutaneous transluminal renal artery angioplasty and stent placement, but there is no definitive evidence and the treatment choice should take into account the risks and potential benefits of the procedure." @default.
• W2163115842 created "2016-06-24" @default.
• W2163115842 creator A5025470433 @default.
• W2163115842 creator A5070213634 @default.
• W2163115842 date "2015-04-01" @default.
• W2163115842 modified "2023-09-24" @default.
• W2163115842 title "From the 1990s to CORAL (Cardiovascular Outcomes in Renal Atherosclerotic Lesions) Trial Results and Beyond: Does Stenting Have a Role in Ischemic Nephropathy?" @default.
• W2163115842 cites W1560486856 @default.
• W2163115842 cites W1968515316 @default.
• W2163115842 cites W1969816726 @default.
• W2163115842 cites W1974150453 @default.
• W2163115842 cites W1976636520 @default.
• W2163115842 cites W1976834810 @default.
• W2163115842 cites W1979816118 @default.
• W2163115842 cites W1984139402 @default.
• W2163115842 cites W1991906068 @default.
• W2163115842 cites W1992666640 @default.
• W2163115842 cites W1997879237 @default.
• W2163115842 cites W1999059869 @default.
• W2163115842 cites W2002245828 @default.
• W2163115842 cites W2018981541 @default.
• W2163115842 cites W2027550955 @default.
• W2163115842 cites W2028733661 @default.
• W2163115842 cites W2037518178 @default.
• W2163115842 cites W2037989593 @default.
• W2163115842 cites W2051209176 @default.
• W2163115842 cites W2070904782 @default.
• W2163115842 cites W2094727696 @default.
• W2163115842 cites W2097552698 @default.
• W2163115842 cites W2110042341 @default.
• W2163115842 cites W2112948259 @default.
• W2163115842 cites W2114300243 @default.
• W2163115842 cites W2115855000 @default.
• W2163115842 cites W2117157033 @default.
• W2163115842 cites W2122238500 @default.
• W2163115842 cites W2123928295 @default.
• W2163115842 cites W2132236275 @default.
• W2163115842 cites W2145766020 @default.
• W2163115842 cites W2148367988 @default.
• W2163115842 cites W2151584545 @default.
• W2163115842 cites W2154627153 @default.
• W2163115842 cites W2157712704 @default.
• W2163115842 cites W2164431614 @default.
• W2163115842 cites W2168330287 @default.
• W2163115842 cites W2301562538 @default.
• W2163115842 cites W2422533597 @default.
• W2163115842 cites W4234221464 @default.
• W2163115842 doi "https://doi.org/10.1053/j.ajkd.2014.11.026" @default.
• W2163115842 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25649878" @default.
• W2163115842 hasPublicationYear "2015" @default.
• W2163115842 type Work @default.
• W2163115842 sameAs 2163115842 @default.
• W2163115842 citedByCount "7" @default.
• W2163115842 countsByYear W21631158422016 @default.
• W2163115842 countsByYear W21631158422018 @default.
• W2163115842 countsByYear W21631158422020 @default.
• W2163115842 countsByYear W21631158422022 @default.
• W2163115842 countsByYear W21631158422023 @default.
• W2163115842 crossrefType "journal-article" @default.
• W2163115842 hasAuthorship W2163115842A5025470433 @default.
• W2163115842 hasAuthorship W2163115842A5070213634 @default.
• W2163115842 hasConcept C126322002 @default.
• W2163115842 hasConcept C141071460 @default.
• W2163115842 hasConcept C164705383 @default.
• W2163115842 hasConcept C2776634560 @default.
• W2163115842 hasConcept C2778583881 @default.
• W2163115842 hasConcept C2779464278 @default.
• W2163115842 hasConcept C2780091579 @default.
• W2163115842 hasConcept C2780326628 @default.
• W2163115842 hasConcept C2781016617 @default.
• W2163115842 hasConcept C2908647359 @default.
• W2163115842 hasConcept C500558357 @default.
• W2163115842 hasConcept C71924100 @default.
• W2163115842 hasConcept C99454951 @default.
• W2163115842 hasConceptScore W2163115842C126322002 @default.
• W2163115842 hasConceptScore W2163115842C141071460 @default.
• W2163115842 hasConceptScore W2163115842C164705383 @default.
• W2163115842 hasConceptScore W2163115842C2776634560 @default.
• W2163115842 hasConceptScore W2163115842C2778583881 @default.
• W2163115842 hasConceptScore W2163115842C2779464278 @default.
• W2163115842 hasConceptScore W2163115842C2780091579 @default.
• W2163115842 hasConceptScore W2163115842C2780326628 @default.
• W2163115842 hasConceptScore W2163115842C2781016617 @default.
• W2163115842 hasConceptScore W2163115842C2908647359 @default.
• W2163115842 hasConceptScore W2163115842C500558357 @default.
• W2163115842 hasConceptScore W2163115842C71924100 @default.
• W2163115842 hasConceptScore W2163115842C99454951 @default.
• W2163115842 hasIssue "4" @default.
• W2163115842 hasLocation W21631158421 @default.
• W2163115842 hasLocation W21631158422 @default.
• W2163115842 hasOpenAccess W2163115842 @default.
• W2163115842 hasPrimaryLocation W21631158421 @default.
• W2163115842 hasRelatedWork W130819809 @default.
• W2163115842 hasRelatedWork W2037513719 @default.
• W2163115842 hasRelatedWork W2092702154 @default.
• W2163115842 hasRelatedWork W2127657496 @default.
• W2163115842 hasRelatedWork W2205576800 @default.
• W2163115842 hasRelatedWork W2478747641 @default.

• next